» Articles » PMID: 23849087

The MHC I Loading Complex: a Multitasking Machinery in Adaptive Immunity

Overview
Specialty Biochemistry
Date 2013 Jul 16
PMID 23849087
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Recognition and elimination of virally or malignantly transformed cells are pivotal tasks of the adaptive immune system. For efficient immune detection, snapshots of the cellular proteome are presented as epitopes on major histocompatibility complex class I (MHC I) molecules for recognition by cytotoxic T cells. Knowledge about the track from the equivocal protein to the presentation of antigenic peptides has greatly expanded, leading to an astonishingly elaborate understanding of the MHC I peptide loading pathway. Here, we summarize the current view on this complex process, which involves ABC transporters, proteases, chaperones, and endoplasmic reticulum (ER) quality control. The contribution of individual proteins and subcomplexes is discussed, with a focus on the architecture and dynamics of the key player in the pathway, the peptide-loading complex (PLC).

Citing Articles

Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy.

Almawash S Cancers (Basel). 2025; 17(5).

PMID: 40075727 PMC: 11899125. DOI: 10.3390/cancers17050880.


Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.

Zielinska M, Ciazynska M, Sulejczak D, Rutkowski P, Czarnecka A Biomolecules. 2025; 15(2).

PMID: 40001572 PMC: 11853485. DOI: 10.3390/biom15020269.


Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance.

Mei T, Ye T, Huang D, Xie Y, Xue Y, Zhou D Cell Oncol (Dordr). 2024; 47(6):2049-2071.

PMID: 39565509 DOI: 10.1007/s13402-024-01009-6.


Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer.

Yao H, Huang C, Zou J, Liang W, Zhao Y, Yang K J Extracell Vesicles. 2024; 13(7):e12484.

PMID: 39041344 PMC: 11263977. DOI: 10.1002/jev2.12484.


A genetic variant in the TAPBP gene enhances cervical cancer susceptibility by increasing mA modification.

Hu J, Wang S, Zhang X, Yan W, Liu H, Chen X Arch Toxicol. 2024; 98(10):3425-3438.

PMID: 38992170 DOI: 10.1007/s00204-024-03820-4.